Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase III trial is to evaluate the efficacy of intravaginal
dehydroepiandrosterone (DHEA) in postmenopausal women with vaginal atrophy.